AAAAAA

   
Results: 1-12 |
Results: 12

Authors: FRY DW BRIDGES AJ DENNY WA DOHERTY A GREIS KD HICKS JL HOOK KE KELLER PR LEOPOLD WR LOO JA MCNAMARA DJ NELSON JM SHERWOOD V SMAILL JB TRUMPPKALLMEYER S DOBRUSIN EM
Citation: Dw. Fry et al., SPECIFIC, IRREVERSIBLE INACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ERBB2, BY A NEW CLASS OF TYROSINE KINASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 95(20), 1998, pp. 12022-12027

Authors: BIKKER JA TRUMPPKALLMEYER S HUMBLET C
Citation: Ja. Bikker et al., G-PROTEIN COUPLED RECEPTORS - MODELS, MUTAGENESIS, AND DRUG DESIGN, Journal of medicinal chemistry, 41(16), 1998, pp. 2911-2927

Authors: TRUMPPKALLMEYER S RUBIN JR HUMBLET C HAMBY JM SHOWALTER HDH
Citation: S. Trumppkallmeyer et al., DEVELOPMENT OF A BINDING MODEL TO PROTEIN-TYROSINE KINASES FOR SUBSTITUTED PYRIDO[2,3-D]PYRIMIDINE INHIBITORS, Journal of medicinal chemistry, 41(11), 1998, pp. 1752-1763

Authors: BOURDON H TRUMPPKALLMEYER S SCHREUDER H HOFLACK J HIBERT M WERMUTH CG
Citation: H. Bourdon et al., MODELING OF THE BINDING-SITE OF THE HUMAN M(1) MUSCARINIC RECEPTOR - EXPERIMENTAL VALIDATION AND REFINEMENT, Journal of computer-aided molecular design, 11(4), 1997, pp. 317-332

Authors: PALMER BD TRUMPPKALLMEYER S FRY DW NELSON JM SHOWALTER HDH DENNY WA
Citation: Bd. Palmer et al., TYROSINE KINASE INHIBITORS .11. SOLUBLE ANALOGS OF PYRROLOQUINAZOLINES AND PYRAZOLOQUINAZOLINES AS EPIDERMAL GROWTH-FACTOR RECEPTOR INHIBITORS - SYNTHESIS, BIOLOGICAL EVALUATION, AND MODELING OF THE MODE OF BINDING, Journal of medicinal chemistry, 40(10), 1997, pp. 1519-1529

Authors: CHINI B MOUILLAC B BALESTRE MN TRUMPPKALLMEYER S HOFLACK J HIBERT M ANDRIOLO M PUPIER S JARD S BARBERIS C
Citation: B. Chini et al., 2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN, FEBS letters, 397(2-3), 1996, pp. 201-206

Authors: CHINI B MOUILLAC B ALA Y BALESTRE MN TRUMPPKALLMEYER S HOFLACK J ELANDS J HIBERT M MANNING M JARD S BARBERIS C
Citation: B. Chini et al., TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR, EMBO journal, 14(10), 1995, pp. 2176-2182

Authors: HIBERT M HOFLACK J TRUMPPKALLMEYER S PAQUET JL LEPPIK R BARBERIS C MOUILLAC B CHINI B JARD S
Citation: M. Hibert et al., 3D MODELS OF HORMONE RECEPTORS - EXPERIMENTAL VALIDATION, European journal of medicinal chemistry, 30, 1995, pp. 189-199

Authors: MOUILLAC B CHINI B BALESTRE MN ELANDS J TRUMPPKALLMEYER S HOFLACK J HIBERT M JARD S BARBERIS C
Citation: B. Mouillac et al., THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS, The Journal of biological chemistry, 270(43), 1995, pp. 25771-25777

Authors: HOFLACK J TRUMPPKALLMEYER S HIBERT M
Citation: J. Hoflack et al., REEVALUATION OF BACTERIORHODOPSIN AS A MODEL FOR G-PROTEIN-COUPLED RECEPTORS, Trends in pharmacological sciences, 15(1), 1994, pp. 7-9

Authors: HERBETTE L GALLION S RHODES D HIBERT M HOFLACK J TRUMPPKALLMEYER S JENKINS D TRUMBORE M
Citation: L. Herbette et al., MOLECULAR DYNAMIC SIMULATIONS OF DRUGS, PEPTIDES AND PROTEINS IN LIPID BILAYERS, Biophysical journal, 66(2), 1994, pp. 10000386-10000386

Authors: HUGGINS JP TRUMPPKALLMEYER S HIBERT MF HOFLACK JM FANGER BO JONES CR
Citation: Jp. Huggins et al., MODELING AND MODIFICATION OF THE BINDING-SITE OF ENDOTHELIN AND OTHERRECEPTORS, European journal of pharmacology. Molecular pharmacology section, 245(3), 1993, pp. 203-214
Risultati: 1-12 |